PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,000 | -50.0% | 2,916 | -50.6% | 0.00% | – |
| Q3 2019 | $30,000 | -38.8% | 5,898 | -25.8% | 0.00% | – |
| Q2 2019 | $49,000 | -7.5% | 7,949 | -29.2% | 0.00% | – |
| Q1 2019 | $53,000 | 0.0% | 11,229 | -11.2% | 0.00% | -100.0% |
| Q4 2018 | $53,000 | +1666.7% | 12,651 | +2466.1% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 493 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 493 | -5.2% | 0.00% | – |
| Q1 2018 | $4,000 | +33.3% | 520 | +2.6% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 507 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | -92.0% | 507 | -93.1% | 0.00% | -100.0% |
| Q2 2017 | $50,000 | +733.3% | 7,379 | +1165.7% | 0.00% | – |
| Q1 2017 | $6,000 | +100.0% | 583 | +51.8% | 0.00% | – |
| Q4 2016 | $3,000 | -66.7% | 384 | -71.8% | 0.00% | – |
| Q3 2016 | $9,000 | – | 1,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|